Secondary Logo

Journal Logo

Most Popular Articles

Adherence to Antipsychotic Medication in Bipolar Disorder and Schizophrenic Patients: A Systematic Review

García, Saínza; Martínez-Cengotitabengoa, Mónica; López-Zurbano, Saioa; More

Journal of Clinical Psychopharmacology. 36(4):355-371, August 2016.

Efficacy and Safety of Paliperidone Palmitate Treatment in Patients With Schizophrenia: A Real-World Multicenter, Retrospective, Mirror-Image Study

Devrimci-Ozguven, Halise; Atmaca, Murad; Baran, Zeynep; More

Journal of Clinical Psychopharmacology. 39(6):604-610, November/December 2019.

Comparison of the Metabolic Characteristics of Newer Second Generation Antipsychotics: Brexpiprazole, Lurasidone, Asenapine, Cariprazine, and Iloperidone With Olanzapine as a Comparator

Greger, Jessica; Aladeen, Traci; Lewandowski, Emily; More

Journal of Clinical Psychopharmacology. 41(1):5-12, January/February 2021.

Zonisamide, Topiramate, and Levetiracetam: Efficacy and Neuropsychological Effects in Alcohol Use Disorders

Knapp, Clifford M.; Ciraulo, Domenic A.; Sarid-Segal, Ofra; More

Journal of Clinical Psychopharmacology. 35(1):34-42, February 2015.

Assessment of the Abuse Potential of Cebranopadol in Nondependent Recreational Opioid Users: A Phase 1 Randomized Controlled Study

Göhler, Karin; Sokolowska, Marta; Schoedel, Kerri A.; More

Journal of Clinical Psychopharmacology. 39(1):46-56, January/February 2019.

A Phase 3, 1-Year, Open-Label Trial of Valbenazine in Adults With Tardive Dyskinesia

Marder, Stephen R.; Singer, Carlos; Lindenmayer, Jean-Pierre; More

Journal of Clinical Psychopharmacology. 39(6):620-627, November/December 2019.

Speed of Improvement in Symptoms of Depression With Desvenlafaxine 50 mg and 100 mg Compared With Placebo in Patients With Major Depressive Disorder

Katzman, Martin A.; Nierenberg, Andrew A.; Wajsbrot, Dalia B.; More

Journal of Clinical Psychopharmacology. 37(5):555-561, October 2017.

Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression: A SPECT Study

Sanches, Rafael Faria; de Lima Osório, Flávia; dos Santos, Rafael G.; More

Journal of Clinical Psychopharmacology. 36(1):77-81, February 2016.

N-Acetylcysteine Add-On Treatment in Refractory Obsessive-Compulsive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial

Afshar, Hamid; Roohafza, Hamidreza; Mohammad-Beigi, Hamid; More

Journal of Clinical Psychopharmacology. 32(6):797-803, December 2012.

Effects of Pharmacogenetic Screening for CYP2D6 Among Elderly Starting Therapy With Nortriptyline or Venlafaxine: A Pragmatic Randomized Controlled Trial (CYSCE Trial)

van der Schans, Jurjen; Hak, Eelko; Postma, Maarten; More

Journal of Clinical Psychopharmacology. 39(6):583-590, November/December 2019.

Treating Opioid Use Disorder With a Monthly Subcutaneous Buprenorphine Depot Injection: 12-Month Safety, Tolerability, and Efficacy Analysis

Andorn, Anne C.; Haight, Barbara R.; Shinde, Sunita; More

Journal of Clinical Psychopharmacology. 40(3):231-239, May/June 2020.

Comparison of Paliperidone Palmitate and Risperidone Long-Acting Injection in Schizophrenic Patients: Results From a Multicenter Retrospective Cohort Study in France

Limosin, Frédéric; Belhadi, Drifa; Comet, Denis; More

Journal of Clinical Psychopharmacology. 38(1):19-26, February 2018.

Guideline Adherence of Monitoring Antipsychotic Use for Nonpsychotic Indications in Children and Adolescents: A Patient Record Review

Dinnissen, Mariken; Dietrich, Andrea; van der Molen, Judith H.; More

Journal of Clinical Psychopharmacology. 41(1):13-18, January/February 2021.

A Pilot Study of the Usefulness of a Single Olanzapine Plasma Concentration as an Indicator of Early Drug Effect in a Small Sample of First-Episode Psychosis Patients

Zabala, Arantzazu; Bustillo, Mariana; Querejeta, Imanol; More

Journal of Clinical Psychopharmacology. 37(5):569-577, October 2017.

Clozapine Response in Schizophrenia and Hematological Changes

Blackman, Graham; Lisshammar, Jenny E.L.; Zafar, Rayyan; More

Journal of Clinical Psychopharmacology. 41(1):19-24, January/February 2021.

Six-Month Randomized, Placebo-Controlled, Double-Blind, Pilot Clinical Trial of Curcumin in Patients With Alzheimer Disease

Baum, Larry; Lam, Christopher Wai Kei; Cheung, Stanley Kwok-Kuen; More

Journal of Clinical Psychopharmacology. 28(1):110-113, February 2008.

Assessment of Pharmacokinetic and Pharmacodynamic Interactions Between Albumin-Fused Mutated Butyrylcholinesterase and Intravenously Administered Cocaine in Recreational Cocaine Users

Shram, Megan J.; Cohen-Barak, Orit; Chakraborty, Bijan; More

Journal of Clinical Psychopharmacology. 35(4):396-405, August 2015.

The Prescription of Benzodiazepines for Panic Disorder: Time for an Evidence-Based Educational Approach

Nardi, Antonio E.; Cosci, Fiammetta; Balon, Richard; More

Journal of Clinical Psychopharmacology. 38(4):283-285, August 2018.

Randomized Controlled Crossover Trials of the Pharmacokinetics of PRC-063, a Novel Multilayer Extended-Release Formulation of Methylphenidate, in Healthy Adults

Katzman, Martin A.; Mattingly, Greg; Klassen, Larry J.; More

Journal of Clinical Psychopharmacology. 40(6):579-587, November/December 2020.

Clonidine Improves Hyperarousal in Borderline Personality Disorder With or Without Comorbid Posttraumatic Stress Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial

Ziegenhorn, Andreas A.; Roepke, Stefan; Schommer, Nicole C.; More

Journal of Clinical Psychopharmacology. 29(2):170-173, April 2009.

RE-KINECT: A Prospective Study of the Presence and Healthcare Burden of Tardive Dyskinesia in Clinical Practice Settings

Caroff, Stanley N.; Yeomans, Karen; Lenderking, William R.; More

Journal of Clinical Psychopharmacology. 40(3):259-268, May/June 2020.

Polymorphism of rs3813034 in Serotonin Transporter Gene SLC6A4 Is Associated With the Selective Serotonin and Serotonin-Norepinephrine Reuptake Inhibitor Response in Depressive Disorder: Sequencing Analysis of SLC6A4

Nonen, Shinpei; Kato, Masaki; Takekita, Yoshiteru; More

Journal of Clinical Psychopharmacology. 36(1):27-31, February 2016.

Long-Term Effect of Haloperidol, Olanzapine, and Risperidone on Plasma Prolactin Levels in Patients With First-Episode Psychosis

Pérez-Iglesias, Rocio; Mata, Ignacio; Martínez-García, Obdulia; More

Journal of Clinical Psychopharmacology. 32(6):804-808, December 2012.

Prebiotic Treatment Increases Serum Butyrate in People With Schizophrenia: Results of an Open-Label Inpatient Pilot Clinical Trial

Kelly, Deanna L.; Kane, Maureen A.; Fraser, Claire M.; More

Journal of Clinical Psychopharmacology. 41(2):200-202, March/April 2021.

Paliperidone Palmitate Once-Monthly Injectable Treatment for Acute Exacerbations of Schizoaffective Disorder

Fu, Dong-Jing; Turkoz, Ibrahim; Simonson, R. Bruce; More

Journal of Clinical Psychopharmacology. 36(4):372-376, August 2016.

Aripiprazole Once-Monthly in the Treatment of Acute Psychotic Episodes in Schizophrenia: Post Hoc Analysis of Positive and Negative Syndrome Scale Marder Factor Scores

Ismail, Zahinoor; Peters-Strickland, Timothy; Miguelez, Maia; More

Journal of Clinical Psychopharmacology. 37(3):347-350, June 2017.

A 12-Week Double-Blind, Placebo-Controlled Study of Bupropion SR Added to High-Dose Dual Nicotine Replacement Therapy for Smoking Cessation or Reduction in Schizophrenia

Evins, A. Eden; Cather, Corinne; Culhane, Melissa A.; More

Journal of Clinical Psychopharmacology. 27(4):380-386, August 2007.

Influence of Dose, Cigarette Smoking, Age, Sex, and Metabolic Activity on Plasma Clozapine Concentrations: A Predictive Model and Nomograms to Aid Clozapine Dose Adjustment and to Assess Compliance in Individual Patients

Rostami-Hodjegan, Amin; Amin, Ajmal M.; Spencer, Edgar P.; More

Journal of Clinical Psychopharmacology. 24(1):70-78, February 2004.

Omega-3 Fatty Acids, Depressive Symptoms, and Cognitive Performance in Patients With Coronary Artery Disease: Analyses From a Randomized, Double-Blind, Placebo-Controlled Trial

Mazereeuw, Graham; Herrmann, Nathan; Oh, Paul I.; More

Journal of Clinical Psychopharmacology. 36(5):436-444, October 2016.

Lower Prolactin Levels in Patients Treated With Aripiprazole Regardless of Antipsychotic Monopharmacy or Polypharmacy

Sugai, Takuro; Suzuki, Yutaro; Yamazaki, Manabu; More

Journal of Clinical Psychopharmacology. 40(1):14-17, January/February 2020.

Improvement in Subjective and Objective Neurocognitive Functions in Patients With Major Depressive Disorder: A 12-Week, Multicenter, Randomized Trial of Tianeptine Versus Escitalopram, the CAMPION Study

Jeon, Hong Jin; Woo, Jong-Min; Lee, Seung-Hwan; More

Journal of Clinical Psychopharmacology. 34(2):218-225, April 2014.

Show: